| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 719.26M | 767.54M | 852.39M | 714.71M | 341.86M |
| Gross Profit | 172.38M | 466.20M | 487.83M | 440.62M | 194.67M |
| EBITDA | 39.89M | 111.00M | 127.23M | 97.33M | 16.67M |
| Net Income | -31.28M | 22.85M | 36.33M | 20.23M | -32.21M |
Balance Sheet | |||||
| Total Assets | 1.22B | 1.33B | 1.21B | 1.16B | 1.04B |
| Cash, Cash Equivalents and Short-Term Investments | 156.75M | 236.39M | 179.01M | 176.85M | 157.99M |
| Total Debt | 525.08M | 517.37M | 507.13M | 501.23M | 526.33M |
| Total Liabilities | 822.94M | 850.56M | 917.82M | 883.69M | 792.60M |
| Stockholders Equity | 292.31M | 378.03M | 240.04M | 221.48M | 197.41M |
Cash Flow | |||||
| Free Cash Flow | -64.63M | -121.94M | 28.22M | 60.82M | -50.66M |
| Operating Cash Flow | -12.05M | -34.98M | 91.15M | 87.61M | -23.93M |
| Investing Cash Flow | -54.27M | -85.63M | -60.98M | -22.43M | -6.64M |
| Financing Cash Flow | -10.33M | 183.89M | -35.12M | -38.10M | 11.05M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | €3.01B | -78.76 | 3.97% | 4.82% | -3.02% | 43.07% | |
52 Neutral | €557.81M | 297.92 | -6.41% | ― | 1.39% | 72.34% | |
48 Neutral | €362.42M | -3.44 | -92.71% | ― | -16.41% | -952.46% | |
41 Neutral | €364.92M | -13.10 | 11.13% | 6.29% | -10.37% | 38.82% |
Spanish shareholders Corporación JM Aristrain and Torre Rioja-Madrid SOCIMI have amended their shareholders’ agreement regarding their stakes in Tubacex, S.A. The addendum clarifies that their share syndication is strictly limited to coordinating voting rights to support the appointment of a single proprietary director representing Torre Rioja on Tubacex’s board.
Under the revised terms, the parties agree to align their political rights attached to Torre Rioja’s entire holding and Corporación Aristrain’s 3.18% stake solely to propose, elect, and maintain Ángel Soria Vaquerizo as proprietary director. This narrows the scope of their cooperation to board representation, signaling that the pact is not intended as a broader concerted action over Tubacex’s corporate control or wider governance matters.
The most recent analyst rating on (ES:TUB) stock is a Hold with a EUR3.50 price target. To see the full list of analyst forecasts on Tubacex stock, see the ES:TUB Stock Forecast page.
Tubacex has formalized a set of Board of Directors Regulations that define how the board and its committees are organized, how they operate, and what standards of conduct apply to directors, the non‑director secretary, and senior managers. The rules are designed to align with applicable laws, the company’s bylaws, and Spain’s Unified Code of Good Governance, with the Board Secretary empowered to resolve interpretative doubts.
The regulations also establish a clear process for amendment, allowing changes to be proposed by the chair, a third of directors, or any committee, and requiring prior reports from the Audit and Compliance Committee and, where relevant, other affected committees. Any modification must be circulated at least ten days before the meeting and approved by a two‑thirds majority of the full board for each substantially independent matter, reinforcing rigor and transparency in corporate governance changes.
The most recent analyst rating on (ES:TUB) stock is a Hold with a EUR3.50 price target. To see the full list of analyst forecasts on Tubacex stock, see the ES:TUB Stock Forecast page.
Tubacex has announced that it will release its 2025 annual results on February 27, 2026, before the opening of financial markets, and will present the figures to investors and analysts via a webcast later that morning. The scheduled disclosure underlines the company’s adherence to market transparency requirements and provides a clear timetable for shareholders and other stakeholders to assess its performance and outlook for the past financial year.
The most recent analyst rating on (ES:TUB) stock is a Hold with a EUR3.50 price target. To see the full list of analyst forecasts on Tubacex stock, see the ES:TUB Stock Forecast page.
Tubacex has notified the market that it will publish its 2025 annual results on Friday, 27 February 2026, before the opening of financial markets, and will present the figures to investors and analysts via a webcast later that morning. The scheduled disclosure underlines the company’s adherence to market transparency requirements and provides stakeholders with a clear timetable for assessing Tubacex’s financial and operational performance for 2025.
The most recent analyst rating on (ES:TUB) stock is a Hold with a EUR3.50 price target. To see the full list of analyst forecasts on Tubacex stock, see the ES:TUB Stock Forecast page.